Answers are grounded in this paper and cite their sources.
Selenium functions in biological systems by acting as an antioxidant at normal levels and as a pro-oxidant at higher concentrations. This dual role may help in cancer prevention by causing oxidative stress and targeting cancer cells selectively. This review aims to critically synthesize current knowledge about selenium’s prooxidant role in cancer prevention, explaining the molecular mechanisms, epidemiological links, dependence on form and dose, genetic factors that affect response and the outcomes of intervention studies. The goal is to guide future translational and therapeutic strategies. Epidemiological and intervention studies show that regional differences in selenium levels influence cancer risk, highlighting the complex connection between selenium intake and cancer prevention. Genetic polymorphisms and epigenetic changes that affect selenoprotein expression also modulate individual responses to selenium supplements. Advances in selenium delivery methods, such as nanoparticle formulations and conjugation with chemotherapeutics, enhance its anticancer effectiveness and specificity while minimizing toxicity. Interactions between selenium and other minerals or drugs also impact its chemopreventive potential. Although mechanistic insights and preclinical data are promising, clinical trial results are inconsistent, emphasizing the need for personalized selenium supplementation based on baseline levels, genetic factors, and optimal doses to maximize its cancer-preventive benefits.
No takes yet. Share an insight, caveat, or question.
Qadir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: